CYTAX 300 (Paclitaxel 6mg/ml) 300mg/50ml MULTI-DOSE VIAL INTRAVENOUS INJECTION.

Rated 0 out of 5
(0 customer reviews)

Description: Cytax 300 (paclitaxel) is an antimicrotubule agent in cancer chemotherapy. It promotes microtubule assembly and stabilizes microtubules, inhibiting their normal dynamic reorganization. This stability disrupts vital cellular functions, leading to cell death. It is commonly used for ovarian cancer, non-small cell lung cancer, and breast cancer.

50,100.00

Hurry Up! Sales Ends In:

In stock

Guaranteed Safe Checkout

CYTAX 300 (Paclitaxel 6mg/ml) 300mg/50ml MULTI-DOSE VIAL INTRAVENOUS INJECTION.
Generic name: Paclitaxel
Brand name: Intas Pharmaceutical.
Class: Antineoplastic (Chemotherapy Drug)
Pack size: 50ml
Form: Injection
Strength: 6mg/ml
Amount: ₦‎50,100

Description: Cytax contains Paclitaxel, a chemotherapeutic agent used in cancer treatment. This medication is available in a 6mg/ml strength and must be diluted before administration. It is used under the supervision of a qualified oncologist to treat various types of cancers, including breast, ovarian, and lung cancer.

Key features:
• Concentration: 6mg/ml
• Packaging: Multi-Dose vial.
• For intravenous use.

Side Effects:
Common side effects include:
• Nausea and vomiting
• Hair loss
• Bone marrow suppression (low blood cell counts)
• Neuropathy (nerve damage leading to tingling or numbness)
• Fatigue
• diarrhoea
• Increased risk of infections

Caution:
• Only to be used under the guidance of a trained oncologist.
• Monitor for allergic reactions during infusion.
• Contraindicated in patients with hypersensitivity to Paclitaxel.
• Use with caution in patients with liver impairment.
• Regular blood tests required to monitor blood cell levels.
• Pregnancy Category D: May cause harm to a fetus.
• Avoid use in breastfeeding mothers.

Weight 113 g

Reviews

There are no reviews yet.

Be the first to review “CYTAX 300 (Paclitaxel 6mg/ml) 300mg/50ml MULTI-DOSE VIAL INTRAVENOUS INJECTION.”

Your email address will not be published. Required fields are marked *

Back To Top